DRUG · Mapped RxNorm record
Pemetrexed
Normalized identity: pemetrexedView linked drug · Find medicine records ·
Find other trials using this name
Clinical trial
Pemetrexed and Gemcitabine in Patients With Advanced Non-Small Cell Lung Cancer
NCT00193414
Drugs and interventions used in this trial
2 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Mapped RxNorm record
Gemcitabine
Normalized identity: gemcitabineView linked drug · Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedPemetrexed and Gemcitabine in Patients With Advanced Non-Small Cell Lung Cancer
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Lung Cancerverified · MONDO: lung cancer
Interventions
PemetrexedDRUG · verified · RxNorm: pemetrexed
GemcitabineDRUG · verified · RxNorm: gemcitabine
Sponsors & collaborators
SCRI Development Innovations, LLClead sponsor
Eli Lilly and Companycollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00193414 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.